[Thermoanalytic determination of the enantiomeric purity of selegiline].
The thermal behaviour of Selegiline (a chiral, non racemic pharmaceutical used in the therapy of Parkinson disease) was studied by differential scanning calorimetry (DSC) for determining the enantiomeric purity (e.p.) of the bulk substance. It has been found, that (i) the binary phase diagram (melting point phase diagram) of the R/S enantiomer mixtures is characteristic to that of the true racemic compounds; (ii) the melting behaviour of the R/S binary mixtures follows the thermodynamic laws (i.e. the Schröder-Van Laar and the Prigogine-Defay equations); (iii) the e.p. of the highly purified bulk substance can be expressed as "DSC purity" (this latter is obtained from the Van't Hoff equation) and the microcalorimetric method as above gives good reproducibility; (iv) due to the minor impurities (other than the S(-) enantiomer) the obtained e.p. (expressed as DSC purity) can be higher but not lower than the actual e.p. of the investigated substance.
Ladányi
L
L
Szilágyi
I
I
Hermecz
I
I
D002152:Calorimetry, Differential Scanning; D012642:Selegiline / Q000737:chemistry*; D013237:Stereoisomerism
D012642:Selegiline
A selegilin enantiomertisztaságának vizsgálata termoanalitikai módszerekkel.